| Literature DB >> 30083107 |
Breno Q Farah1,2, Sergio L C Rodrigues1,2, Gustavo O Silva1, Rodrigo P Pedrosa3, Marilia A Correia4, Mauro V G Barros1, Rafael Deminice5, Poliana C Marinello5, Neil A Smart6, Lauro C Vianna7, Raphael M Ritti-Dias8.
Abstract
Meta-analyses have shown that supervised isometric handgrip training reduces blood pressure in hypertensives. However, the mechanism(s) underlying these effects in medicated hypertensive patients, as well as the effects from home-based exercise training, is uncertain. The purpose of this study was to compare the effects of supervised and home-based isometric handgrip training on cardiovascular parameters in medicated hypertensives. In this randomized controlled trial, 72 hypertensive individuals (38-79 years old, 70% female) were randomly assigned to three groups: home-based, supervised isometric handgrip training or control groups. Home-based and supervised isometric handgrip training was completed thrice weekly (4 × 2 min at 30% of maximal voluntary contraction, with 1-min rest between bouts, alternating the hands). Before and after 12 weeks brachial, central and ambulatory blood pressures (BP), arterial stiffness, heart rate variability, vascular function, oxidative stress and inflammation markers were obtained. No significant (p > 0.05) effect was observed for ambulatory BP, arterial stiffness, heart rate variability, vascular function and oxidative stress and inflammatory markers in all three groups. Brachial BP decreased in the supervised group (Systolic: 132 ± 4 vs. 120 ± 3 mmHg; Diastolic: 71 ± 2 vs. 66 ± 2 mmHg, p < 0.05), whereas no significant differences were observed in the home-based (Systolic: 130 ± 4 vs. 126 ± 3 mmHg; diastolic: 73 ± 3 vs. 71 ± 3 mmHg) and control groups (p > 0.05). Supervised handgrip exercise also reduced central BP systolic (120 ± 5 vs. 109 ± 5 mmHg), diastolic (73 ± 2 vs. 67 ± 2 mmHg); and mean BP (93 ± 3 vs. 84 ± 3 mmHg), whereas no significant effects were found in the home-based (Systolic: 119 ± 4 vs. 115 ± 3 mmHg; Diastolic: 74 ± 3 vs. 71 ± 3 mmHg) and control groups (p > 0.05). In conclusion, supervised, but not home-based, isometric training lowered brachial and central BP in hypertensives.Entities:
Keywords: blood pressure; cardiovascular system; exercise; hypertension; resistance training
Year: 2018 PMID: 30083107 PMCID: PMC6065303 DOI: 10.3389/fphys.2018.00961
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
General characteristics of experimental groups at baseline.
| Variables | Control | Home-based | Supervise | |
|---|---|---|---|---|
| Age (years) | 58 ± 3 | 61 ± 2 | 59 ± 2 | 0.753 |
| Weight (kg) | 83.4 ± 3.9 | 80.9 ± 4.0 | 79.1 ± 5.8 | 0.827 |
| Height (m) | 1.61 ± 0.02 | 1.61 ± 0.02 | 1.62 ± 0.03 | 0.970 |
| Body mass index (kg/m2) | 31.7 ± 1.3 | 31.1 ± 1.2 | 29.9 ± 1.7 | 0.655 |
| Brachial systolic BP (mmHg) | 132 ± 4 | 130 ± 4 | 129 ± 5 | 0.908 |
| Brachial diastolic BP (mmHg) | 71 ± 2 | 73 ± 3 | 73 ± 2 | 0.825 |
| Maximal voluntary contraction (kgf) | 29.9 ± 2.3 | 31.7 ± 2.1 | 29.7 ± 3.1 | 0.818 |
| Education level (% low) | 40 | 65 | 79 | 0.312 |
| Sex (% women) | 69 | 72 | 69 | 0.933 |
| Calcium channel blocker (%) | 23 | 17 | 19 | 0.904 |
| Diuretic (%) | 77 | 44 | 38 | 0.083 |
| β-blocker (%) | 23 | 22 | 20 | 0.953 |
| ACE inhibitor (%) | 15 | 33 | 6 | 0.124 |
| Angiotensin receptor blockers (%) | 61 | 77 | 81 | 0.386 |
Effects of home-based and supervised isometric handgrip training and control on ambulatory blood pressure in hypertensives.
| Variables | Supervised | Home-based | Control | ||||
|---|---|---|---|---|---|---|---|
| Pre | Post | Pre | Post | Pre | Post | ||
| Systolic blood pressure (mmHg) | 121 ± 4 | 122 ± 3 | 117 ± 2 | 117 ± 2 | 115 ± 4 | 115 ± 5 | 0.650 |
| Mean blood pressure (mmHg) | 98 ± 4 | 98 ± 2 | 93 ± 2 | 93 ± 2 | 90 ± 2 | 90 ± 3 | 0.463 |
| Diastolic blood pressure (mmHg) | 79 ± 4 | 79 ± 3 | 72 ± 2 | 73 ± 3 | 70 ± 2 | 70 ± 3 | 0.340 |
| Systolic blood pressure (mmHg) | 122 ± 4 | 123 ± 3 | 117 ± 2 | 121 ± 2 | 117 ± 4 | 117 ± 5 | 0.627 |
| Mean blood pressure (mmHg) | 100 ± 4 | 99 ± 2 | 93 ± 2 | 96 ± 2 | 92 ± 2 | 93 ± 4 | 0.611 |
| Diastolic blood pressure (mmHg) | 80 ± 4 | 79 ± 3 | 73 ± 3 | 75 ± 2 | 71 ± 2 | 71 ± 3 | 0.626 |
| Systolic blood pressure (mmHg) | 118 ± 5 | 115 ± 4 | 115 ± 3 | 116 ± 4 | 106 ± 4 | 109 ± 4 | 0.973 |
| Mean blood pressure (mmHg) | 96 ± 5 | 93 ± 4 | 91 ± 2 | 92 ± 4 | 83 ± 3 | 85 ± 3 | 0.971 |
| Diastolic blood pressure (mmHg) | 76 ± 3 | 74 ± 4 | 70 ± 3 | 72 ± 4 | 63 ± 3 | 64 ± 3 | 0.843 |
Effects of home-based and supervised isometric handgrip training and control on cardiovascular parameters in hypertensives.
| Variables | Supervised | Home-based | Control | ||||
|---|---|---|---|---|---|---|---|
| Pre | Post | Pre | Post | Pre | Post | ||
| Pulse pressure (mmHg) | 13.9 ± 3.3 | 11.6 ± 2.6 | 13.2 ± 2.1 | 13.2 ± 2.0 | 13.5 ± 2.2 | 13.3 ± 1.8 | 0.620 |
| Augmentation index (%) | 26.6 ± 4.0 | 25.4 ± 4.0 | 27.2 ± 2.2 | 27.2 ± 2.7 | 27.9 ± 3.2 | 29.1 ± 2.4 | 0.841 |
| Central PWV (m/s) | 8.4 ± 0.4 | 7.7 ± 0.3 | 9.8 ± 0.5 | 8.8 ± 0.3 | 8.7 ± 0.5 | 8.8 ± 0.5 | 0.219 |
| Peripheral PWV (m/s) | 8.3 ± 0.3 | 8.5 ± 0.3 | 8.9 ± 0.4 | 8.9 ± 0.5 | 9.3 ± 0.4 | 9.4 ± 0.4 | 0.960 |
| SDNN (ms) | 39 ± 4 | 38 ± 4 | 29 ± 4 | 31 ± 4 | 38 ± 6 | 39 ± 3 | 0.924 |
| RMSSD (ms) | 31 ± 4 | 32 ± 5 | 21 ± 4 | 27 ± 4 | 33 ± 8 | 30 ± 4 | 0.470 |
| pNN50 (%) | 12 ± 4 | 13 ± 5 | 5 ± 3 | 9 ± 4 | 10 ± 4 | 10 ± 3 | 0.687 |
| Low frequency (nu) | 53 ± 6 | 57 ± 7 | 54 ± 5 | 47 ± 5 | 52 ± 3 | 52 ± 3 | 0.302 |
| High frequency (nu) | 47 ± 6 | 43 ± 7 | 46 ± 5 | 53 ± 5 | 48 ± 3 | 48 ± 3 | 0.302 |
| LF/HF | 2.00 ± 0.74 | 2.26 ± 0.54 | 1.88 ± 0.50 | 1.16 ± 0.23 | 1.28 ± 0.21 | 1.42 ± 0.24 | 0.215 |
| Resting brachial diameter (cm) | 4.01 ± 0.21 | 4.11 ± 0.22 | 4.17 ± 0.21 | 3.97 ± 0.27 | 3.83 ± 0.20 | 3.99 ± 0.20 | 0.122 |
| Resting shear rate (s) | 122 ± 10 | 105 ± 14 | 111 ± 15 | 110 ± 10 | 111 ± 15 | 96 ± 12 | 0.694 |
| AOPP (μM) | 88 ± 21 | 22 ± 6∗ | 71 ± 11 | 57 ± 25 | 67 ± 25 | 11 ± 3∗ | 0.032 |
| MDA (μM) | 1.54 ± 0.22 | 1.15 ± 0.14 | 1.52 ± 0.14 | 1.12 ± 0.13 | 1.53 ± 0.18 | 1.20 ± 0.06 | 0.906 |
| Total Thiols (μM) | 264 ± 19 | 234 ± 32 | 260 ± 31 | 326 ± 95 | 281 ± 13 | 310 ± 76 | 0.453 |
| IL-6 (pg/mL) | 1.36 ± 0.09 | 1.42 ± 0.19 | 1.24 ± 0.15 | 1.49 ± 0.16 | 1.36 ± 0.25 | 1.57 ± 0.15 | 0.669 |
| IL-10 (pg/mL) | 4.6 ± 0.5 | 4.0 ± 0.6 | 5.2 ± 0.4 | 4.9 ± 0.4 | 4.7 ± 0.6 | 4.4 ± 0.5 | 0.952 |
| IL-1b (pg/mL) | 0.32 ± 0.02 | 0.30 ± 0.02 | 0.37 ± 0.02 | 0.34 ± 0.03 | 0.37 ± 0.02 | 0.43 ± 0.04 | 0.328 |
| CRP (pg/mL) | 899 ± 201 | 977 ± 269 | 1812 ± 279 | 1446 ± 485 | 1126 ± 226 | 1188 ± 322 | 0.592 |
| TNF-alpha (pg/mL) | 3.2 ± 0.2 | 4.9 ± 0.7 | 3.5 ± 0.2 | 3.9 ± 0.6 | 9.6 ± 3.8 | 6.6 ± 1.1 | 0.141 |